Simplex Trading, LLC Tricida, Inc. Transaction History

Simplex Trading, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	SELL	$0.14 - $12.49 $2,268 - $202,400	-16,205 Reduced 30.96%	36,145 $5,000
Q3 2022 Nov 04, 2022	BUY	$8.51 - $13.6 $248,755 - $397,541	29,231 Added 126.44%	52,350 $548,000
Q2 2022 Aug 03, 2022	SELL	$7.31 - $11.85 $485,172 - $786,496	-66,371 Reduced 74.17%	23,119 $223,000
Q1 2022 May 02, 2022	BUY	$7.35 - $10.63 $258,565 - $373,952	35,179 Added 64.77%	89,490 $735,000
Q4 2021 Feb 23, 2022	BUY	$4.19 - $9.56 $184,552 - $421,079	44,046 Added 429.09%	54,311 $519,000
Q2 2021 Aug 12, 2021	BUY	$3.95 - $5.41 $26,935 - $36,890	6,819 Added 197.88%	10,265 $44,000
Q1 2021 Apr 26, 2021	BUY	$4.52 - $7.8 $15,575 - $26,878	3,446 New	3,446 $18,000
Q4 2020 Feb 02, 2021	SELL	$4.37 - $9.46 $9,216 - $19,951	-2,109 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$8.56 - $26.93 $18,053 - $56,795	2,109 New	2,109 $19,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.